122 related articles for article (PubMed ID: 2232212)
1. [Allogeneic bone marrow transplantation for acute lymphoblastic leukemia].
Yamauchi T; Ohno R
Nihon Rinsho; 1990 Sep; 48(9):2073-9. PubMed ID: 2232212
[No Abstract] [Full Text] [Related]
2. Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia.
Barrett AJ
Leukemia; 1992; 6 Suppl 2():139-43. PubMed ID: 1578917
[No Abstract] [Full Text] [Related]
3. Bone marrow transplantation for acute lymphoblastic leukaemia in first and second remission.
Barrett AJ; Horowitz MM; McCarthy DM; Kanfer E; Bortin MM
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():247-9. PubMed ID: 2653514
[No Abstract] [Full Text] [Related]
4. Allogeneic bone marrow transplantation for acute leukemia.
Forman SJ; Blume KG
Hematol Oncol Clin North Am; 1990 Jun; 4(3):517-33. PubMed ID: 2193012
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
6. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation in acute lymphoblastic leukemia (ALL).
Santos GW
Leukemia; 1992; 6 Suppl 2():198. PubMed ID: 1578933
[No Abstract] [Full Text] [Related]
8. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic bone marrow transplantation for high risk acute lymphoblastic leukemia. Results from a single institution.
De la Cámara R; Figuera A; Steegmann JL; Tomás JF; López J; Somolinos N; Arranz R; Vázquez L; Fernández Rañada JM
Bone Marrow Transplant; 1992 Jun; 9(6):433-8. PubMed ID: 1628127
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
12. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Aschan J; Ringdén O
Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.
Blaise D; Gaspard MH; Stoppa AM; Michel G; Gastaut JA; Lepeu G; Tubiana N; Blanc AP; Rossi JF; Novakovitch G
Bone Marrow Transplant; 1990 Jan; 5(1):7-12. PubMed ID: 2404531
[TBL] [Abstract][Full Text] [Related]
15. T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.
Przepiorka D; Giralt S; Huh YO; Andreeff M; Luna M; Reading C; Thomas M; Champlin RE
Transplant Proc; 1992 Dec; 24(6):2906-7. PubMed ID: 1465994
[No Abstract] [Full Text] [Related]
16. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
[TBL] [Abstract][Full Text] [Related]
17. Acute lymphoblastic leukemia; factors influencing relapse after allogeneic bone marrow transplantation.
Zwaan FE; Hermans J
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():71. PubMed ID: 2390643
[No Abstract] [Full Text] [Related]
18. Progress in allogeneic and autologous BMT for acute lymphoblastic leukaemia (ALL).
Barrett J
Bone Marrow Transplant; 1991; 7 Suppl 2():59-61. PubMed ID: 1878722
[No Abstract] [Full Text] [Related]
19. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
Chim CS; Lie AK; Liang R; Au WY; Kwong YL
Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect.
Kloosterman TC; Martens AC; van Bekkum DW; Hagenbeek A
Bone Marrow Transplant; 1995 Apr; 15(4):583-90. PubMed ID: 7655385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
